New MDS criteria for clinical diagnosis of MSA

15 February 2022

Delivered by Gregor Wenning and Iva Stankovic – 15 February 2022, 3-4pm CET

This webinar will have two parts, one on ‘MDS criteria for diagnosis of MSA’ to be presented by Gregor Wenning who is Professor and Head of the Division of Clinical Neurobiology at the Medical University Innsbruck. He is also a Co-Founding Director and Coordinator of the European MSA Study Group (www.emsa-sg.org). The other part entitled ‘Introduction and critique of the Gilman criteria’ will be presented by Iva Stankovic, a Neurologist at the Institute of Neurology, University of Belgrade, Serbia.

Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern